Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Nephrotic syndrome Stories

2012-03-07 15:15:00

ANAHEIM, Calif., March 7, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the 24th Annual ROTH Conference to be held on March 11-14, 2012 in Laguna Niguel, CA. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on Monday, March 12, 2012 at 8:30 a.m. PT. A live webcast and subsequent archived replay of the presentation will be accessible at...

2012-02-23 05:30:00

ANAHEIM, Calif., Feb. 23, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Citigroup Global Health Care Conference to be held on February 27-29, 2012 in New York. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on Monday, February 27, 2012 at 9:30 a.m. ET. A live webcast and subsequent archived replay of the presentation will be accessible at...

2012-02-10 05:30:00

ANAHEIM, Calif., Feb. 10, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Leerink Swann Global Healthcare Conference to be held on February 15-16, 2012 in New York. Steve Cartt, Executive Vice President and Chief Business Officer, is scheduled to present an overview of the Company on Thursday, February 16, 2012 at 2:30 p.m. ET. A live webcast and subsequent archived replay of the presentation will be...

2012-02-03 08:15:00

ANAHEIM, Calif., Feb. 3, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it expects to report net sales of approximately $75 million and operating income of approximately $41 million to $43 million for the quarter ended December 31, 2011, as compared to $29.3 million in net sales and $10.8 million in operating income for the quarter ended December 31, 2010. The Company's cash, cash equivalents and short-term investments as of January 31, 2012 was...

2012-01-16 13:09:00

ANAHEIM, Calif., Jan. 16, 2012 /PRNewswire/ -- On January 9, 2012, Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) received a communication from an individual representing herself to be associated with a website identified as StreetSweeper.org ("StreetSweeper"). The individual requested that the Company provide responses to a series of questions about the Company by January 10, 2012. Due to management's schedule, the individual was offered an opportunity to have the questions...

2012-01-11 15:55:00

ANAHEIM, Calif., Jan. 11, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced it became aware that an investor blog is preparing to issue a report regarding the Company's marketing and business practices. Questcor issued the following statement: The Company believes that its marketing and business practices are consistent with regulatory requirements and industry standard practices. Questcor markets H.P. Acthar® Gel for the treatment of acute...

2012-01-06 15:01:00

ANAHEIM, Calif., Jan. 6, 2012 /PRNewswire/ -- In preparation for meetings starting Monday, January 9 with investors and an investor presentation scheduled for 10:00 a.m. Thursday, January 12 at the J. P. Morgan Healthcare Conference, Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced the following preliminary operating metrics for the fourth quarter 2011: -Approximately 935-950 paid H.P. Acthar® Gel (Acthar) prescriptions for the treatment...

2011-12-29 05:30:00

ANAHEIM, Calif., Dec. 29, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the 30th Annual J.P. Morgan Healthcare Conference on January 12, 2012 to be held on January 9-12, 2012 in San Francisco. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on Thursday, January 12, 2012 at 10:00 a.m. ET. A live webcast and subsequent archived replay of the...

2011-12-06 12:40:00

ANAHEIM, Calif., Dec. 6, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Oppenheimer Healthcare Conference to be held on December 13-14, 2011 in New York. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on Tuesday, December 13, 2011 at 2:45 p.m. ET. A live webcast and subsequent archived replay of the presentation will be accessible at...

2011-11-22 15:05:00

ANAHEIM, Calif., Nov. 22, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Piper Jaffray Healthcare Conference to be held on November 29-30, 2011 in New York. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company in an "unplugged" fireside chat and Q&A session on Wednesday, November 30, 2011 at 8:00 a.m. ET. A live audio only webcast and...